Psychedelics as Medicines: An Emerging New Paradigm - PubMed

Affiliations

• PMID: 28019026
• DOI: 10.1002/cpt.557

Review

Psychedelics as Medicines: An Emerging New Paradigm

D E Nichols et al. Clin Pharmacol Ther. 2017 Feb.

Abstract

Scientific interest in serotonergic psychedelics (e.g., psilocybin and LSD; 5-HT_2A receptor agonists) has dramatically increased within the last decade. Clinical studies administering psychedelics with psychotherapy have shown preliminary evidence of robust efficacy in treating anxiety and depression, as well as addiction to tobacco and alcohol. Moreover, recent research has suggested that these compounds have potential efficacy against inflammatory diseases through novel mechanisms, with potential advantages over existing antiinflammatory agents. We propose that psychedelics exert therapeutic effects for psychiatric disorders by acutely destabilizing local brain network hubs and global network connectivity via amplification of neuronal avalanches, providing the occasion for brain network "resetting" after the acute effects have resolved. Antiinflammatory effects may hold promise for efficacy in treatment of inflammation-related nonpsychiatric as well as potentially for psychiatric disorders. Serotonergic psychedelics operate through unique mechanisms that show promising effects for a variety of intractable, debilitating, and lethal disorders, and should be rigorously researched.

Similar articles

• [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].

  Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. Majić T, et al. Fortschr Neurol Psychiatr. 2017 Jul;85(7):383-392. doi: 10.1055/s-0043-103085. Epub 2017 Aug 2. Fortschr Neurol Psychiatr. 2017. PMID: 28768346 Review. German.

• [Classic psychedelic drugs and their potential therapeutic effect].

  Bayat M. Bayat M. Ugeskr Laeger. 2017 Sep 11;179(37):V01170005. Ugeskr Laeger. 2017. PMID: 28918777 Review. Danish.

• Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.

  Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Dos Santos RG, et al. Expert Rev Clin Pharmacol. 2018 Sep;11(9):889-902. doi: 10.1080/17512433.2018.1511424. Epub 2018 Aug 23. Expert Rev Clin Pharmacol. 2018. PMID: 30102078 Review.

• Psychedelics and Personality.

  Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC. Aixalà M, et al. ACS Chem Neurosci. 2018 Oct 17;9(10):2304-2306. doi: 10.1021/acschemneuro.8b00237. Epub 2018 Jun 4. ACS Chem Neurosci. 2018. PMID: 29863323

• Psychedelics and Psychedelic-Assisted Psychotherapy.

  Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM; the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Reiff CM, et al. Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26. Am J Psychiatry. 2020. PMID: 32098487 Review.

Cited by

• Psychedelics and schizophrenia: a double-edged sword.

  Sapienza J, Martini F, Comai S, Cavallaro R, Spangaro M, De Gregorio D, Bosia M. Sapienza J, et al. Mol Psychiatry. 2025 Feb;30(2):679-692. doi: 10.1038/s41380-024-02743-x. Epub 2024 Sep 18. Mol Psychiatry. 2025. PMID: 39294303 Review.

• Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.

  Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L. Kettner H, et al. Front Pharmacol. 2021 Mar 25;12:623985. doi: 10.3389/fphar.2021.623985. eCollection 2021. Front Pharmacol. 2021. PMID: 33995022 Free PMC article.

• [Psychedelic and dissociative agents in psychiatry: challenges in the treatment].

  Jungwirth J, Bavato F, Quednow BB. Jungwirth J, et al. Nervenarzt. 2024 Sep;95(9):803-810. doi: 10.1007/s00115-024-01727-0. Epub 2024 Aug 28. Nervenarzt. 2024. PMID: 39196383 Free PMC article. Review. German.

• Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.

  Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR. Glatfelter GC, et al. ACS Omega. 2022 Jul 5;7(28):24888-24894. doi: 10.1021/acsomega.2c03476. eCollection 2022 Jul 19. ACS Omega. 2022. PMID: 35874244 Free PMC article.

• Psychedelics in the treatment of unipolar and bipolar depression.

  Bosch OG, Halm S, Seifritz E. Bosch OG, et al. Int J Bipolar Disord. 2022 Jul 5;10(1):18. doi: 10.1186/s40345-022-00265-5. Int J Bipolar Disord. 2022. PMID: 35788817 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information